Molecular Vision: Hogewind, Mol Vis 2010; 16:26-35. Table 2

Table 2. Ophthalmological examination results

Patient	Age (Y)	Sex	Mutation reported in WFS1	AoO (Y)	Eye	BCVA	Media	Papilla	Visual field	VEP	Color vision	HRT
II:2	85	F	+	30	RE	0.1	Clear	Optic disc atrophy	Na	Na	Na	Na
					LE	0.05	Clear	Optic disc atrophy	Na	Na	Na	Na
III:2	57	M	+	11	RE	0.1	Clear	Optic disc atrophy	Enlarged blind spot	Delayed response	Marked protan and deutan axes	Outside normal limits
					LE	0.2	Clear	Optic disc atrophy	Enlarged blind spot	Delayed response	Marked protan and deutan axes	Outside normal limits
III:3	50	M	+	10	RE	0.2	Clear	Optic disc atrophy	Enlarged blind spot	Delayed response	Marked protan and deutan axes	Outside normal limits
					LE	0.4	Clear	Optic disc Atrophy	Enlarged blind spot	Delayed response	Marked protan and deutan axes	Outside normal limits
IV:1	26	F	-	11	RE	1.6	Clear	Normal	No significant alterations	Intact	Normal	Normal
					LE	1.2	Clear	Normal	No significant alterations	Intact	Normal	Normal
IV:2	23	M	-	11	RE	1.6	Clear	Normal	No significant alterations	Intact	Normal	Normal
					LE	1.6	Clear	Normal	No significant alterations	Intact	Normal	Normal

For the patients the age in years (Y) is shown as well as whether they carry the WFS1 mutation and their age of onset of ophthalmological complaints (AoO). The results of ophthalmological examination tests are depicted for each eye separately. The mutation carrying individuals all have optic disc atrophy and decreased results of Snellen test for best corrected visual acuity (BCVA). The results of the tests for visual field, visually evoked potentials (VEP), color vision and Heidelberg Retinal Tomography (HRT) were impaired for the affected individuals. The not affected individuals showed normal results for these tests. Abbreviations: female (F); male (M); right eye (RE); left eye (LE); not available (Na).